bufalin has been researched along with Neoplasms in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 6 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Li, M; Li, Y; Liu, Z; Ma, L; Man, S; Meng, Y; Su, Y; Tu, C; Wang, H; Zhou, J | 1 |
| Chen, X; Liu, Q; Liu, Y; Lu, S; Shi, F; Xu, W; Xu, Y | 1 |
| Ghanem, GE; Journe, F; Saussez, S; Soumoy, L | 1 |
| Guo, Q; Liu, D; Liu, TT; Liu, Y; Tu, PF; Yang, H; Yang, Z; Zeng, KW; Zhao, MM; Zhuo, FF | 1 |
| Ali, NM; Cui, X; Dong, Y; Liu, Y; Miao, L; Zhang, B | 1 |
| Che, Y; Liu, K; Qiu, X; Qu, Y; Song, J; Sun, X; Zhang, X; Zhao, X | 1 |
| Chen, M; Chen, P; Shi, F; Tang, L; Wang, Y; Xu, Y; Zheng, M | 1 |
| Chi, H; Meng, Z; Wang, H; Zhang, C | 1 |
| Chen, M; Jin, XF; Qian, C; Xu, XM; Xu, Y; Zhang, X | 1 |
| Jia, T; Liu, C; Liu, T; Ni, Z; Qin, Z; Yuan, X; Yuan, Y | 1 |
| Bian, B; Hayashi, H; He, J; Hirano, T; Kisoh, K; Si, N; Takagi, N; Tanaka, S; Yuan, B; Zhao, HY | 1 |
| Ishii, T; Kira, N; Narahara, H; Nasu, K; Nishida, M; Nishida, Y; Takai, N; Yoshida, T | 1 |
| Tang, D; Tao, X | 1 |
| Nakaya, K | 2 |
6 review(s) available for bufalin and Neoplasms
| Article | Year |
|---|---|
Bufalin for an innovative therapeutic approach against cancer.
Topics: Amphibian Venoms; Antineoplastic Agents; Bufanolides; Cardiac Glycosides; Cell Line, Tumor; Cell Proliferation; Humans; Neoplasms; Tumor Microenvironment | 2022 |
Bufalin: A Systematic Review of Research Hotspots and Antitumor Mechanisms by Text Mining and Bioinformatics.
Topics: Antineoplastic Agents; Apoptosis; Bufanolides; Caspase 3; Cell Proliferation; Computational Biology; Data Mining; Drugs, Chinese Herbal; Gene Expression Regulation, Neoplastic; Molecular Targeted Therapy; Neoplasms; NF-kappa B; Phosphatidylinositol 3-Kinases; Phytotherapy; Proto-Oncogene Proteins c-akt; Signal Transduction | 2020 |
[Research progress of in vitro and in vivo anti-tumor effects and formulation of bufalin].
Topics: Animals; Antineoplastic Agents; Bufanolides; Chemistry, Pharmaceutical; Neoplasms | 2014 |
[Advances in the study of tumor angiogenesis and anti-angiogenic Chinese herbal drugs].
Topics: Angiogenesis Inhibitors; Animals; Bufanolides; Drugs, Chinese Herbal; Ginsenosides; Glucans; Humans; Neoplasms; Neovascularization, Pathologic; Pentacyclic Triterpenes; Phytotherapy; Plants, Medicinal; Polysaccharides; Triterpenes | 2003 |
[On the novel differentiation-apoptosis inducers in tumor cells].
Topics: Animals; Antineoplastic Agents; Apoptosis; Bufanolides; Camptothecin; Cell Differentiation; Etoposide; Humans; Neoplasms; Sodium-Potassium-Exchanging ATPase; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1996 |
[Mechanism of the induction of apoptosis in cancer cells].
Topics: Animals; Antineoplastic Agents; Apoptosis; Bufanolides; Diterpenes; Drug Design; Etoposide; Humans; Neoplasms; Protein Prenylation; Signal Transduction; Topoisomerase I Inhibitors; Ultraviolet Rays | 1996 |
9 other study(ies) available for bufalin and Neoplasms
| Article | Year |
|---|---|
A cardiac glycoside HTF-1 isolated from Helleborus thibetanus Franch displays potent in vitro anti-cancer activity via caspase-9, MAPK and PI3K-Akt-mTOR pathways.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cardiac Glycosides; Caspase 9; Cell Cycle Checkpoints; Cell Line, Tumor; HeLa Cells; Helleborus; Humans; MAP Kinase Signaling System; Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |
Co-delivery of bufalin and nintedanib via albumin sub-microspheres for synergistic cancer therapy.
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Bufanolides; Drug Synergism; Humans; Indoles; Microspheres; Neoplasms; Tumor Microenvironment | 2021 |
Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy.
Topics: E2F2 Transcription Factor; Humans; Neoplasms; Proteolysis; Transcription Factors; Ubiquitin-Protein Ligases; Ubiquitination | 2022 |
Bufalin serves as a pharmaceutic that mitigates drug resistance.
Topics: Biopharmaceutics; Bufanolides; Drug Resistance; Humans; Neoplasms | 2023 |
Tumor-Targeted Delivery of Bufalin-Loaded Modified Albumin-Polymer Hybrid for Enhanced Antitumor Therapy and Attenuated Hemolysis Toxicity and Cardiotoxicity.
Topics: Animals; Antineoplastic Agents; Bufanolides; Cardiotoxicity; Cell Death; Drug Carriers; Hemolysis; Hep G2 Cells; Humans; Nanoparticles; Neoplasms; Particle Size; Polymers; Serum Albumin, Bovine | 2021 |
Synergistic anticancer effects of bufalin and sorafenib by regulating apoptosis associated proteins.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Bufanolides; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Synergism; Humans; Male; Mice; Neoplasms; Niacinamide; Phenylurea Compounds; Sorafenib; Xenograft Model Antitumor Assays | 2018 |
Polymeric prodrug of bufalin for increasing solubility and stability: Synthesis and anticancer study in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Bufanolides; Chemistry, Pharmaceutical; Drug Stability; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Polyethylene Glycols; Polymers; Prodrugs; Solubility; Xenograft Model Antitumor Assays | 2016 |
Effects of active bufadienolide compounds on human cancer cells and CD4+CD25+Foxp3+ regulatory T cells in mitogen-activated human peripheral blood mononuclear cells.
Topics: Antineoplastic Agents; Bufanolides; CD4-Positive T-Lymphocytes; Forkhead Transcription Factors; Humans; Interleukin-2 Receptor alpha Subunit; Leukocytes, Mononuclear; Neoplasms; T-Lymphocytes, Regulatory | 2016 |
Bufalin, a traditional oriental medicine, induces apoptosis in human cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bufanolides; Cell Cycle; Cell Proliferation; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Medicine, East Asian Traditional; Neoplasms; Phytotherapy; Tumor Cells, Cultured | 2012 |